Moderna’s stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
AI-curated news influencing S price, sentiment, and trend
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
US markets (^DJI, ^GSPC, ^IXIC) are still in negative territory but clawing back some ground ahead of Tuesday's market close. …
By the end of trading, the S&P 500 had sunk 0.9%. The index had been down as much as 2.5% …
Best known for its chip business, Broadcom has seen its stock get weighed down by concerns over exposure to software …
Pinterest’s new share-repurchase authorization represents nearly a third of the company’s market cap and signals to one analyst that an …
Palantir should be able to prove its growing value to the military and quell fears that it’s merely an AI …
Multi-Provider AI Analysis